Xtant Medical Holdings, Inc. (AMEX:XTNT) is reporting third quarter earnings results on Thursday 29th October 2020, before market open.
The consensus estimates from Thomson Reuters are loss of $ 0.11 per share.
For the full year, analysts predict revenues of $ 60.50 million, while looking forward to loss of $ 0.52 per share.
Previous Quarter Performance
Xtant Medical Holdings, Inc. came out with loss for the second quarter of $ 0.19 per share, from the revenue of $ 10.53 million.
Stock Performance
Shares of Xtant Medical Holdings, Inc. traded low $ -0.15 or -10.49 percent on Wednesday, reaching $ 1.28 with volume of 123.00 thousand shares. Xtant Medical Holdings, Inc. has traded high as $ 1.42 and has cracked $ 1.27 on the downward trend
According to the previous trading day, closing price of $ 1.28, representing a 160.00 % increase from the 52 week low of $ 0.55 and a 59.14 % decrease over the 52 week high of $ 3.50.
The company has a market capital of $ 92.15 million and is part of the Healthcare sector and Medical Devices industry.
Conference Call
Xtant Medical Holdings, Inc. will be hosting a conference call at 9:00 AM eastern time on 29th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.xtantmedical.com
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system.
